TMO logo

Thermo Fisher Scientific (TMO) Cash and cash equivalents

annual cash & cash equivalents:

$4.01B-$4.07B(-50.37%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TMO annual cash & cash equivalents is $4.01 billion, with the most recent change of -$4.07 billion (-50.37%) on December 31, 2024.
  • During the last 3 years, TMO annual cash & cash equivalents has fallen by -$468.00 million (-10.45%).
  • TMO annual cash & cash equivalents is now -61.17% below its all-time high of $10.32 billion, reached on December 31, 2020.

Performance

TMO Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMObalance sheet metrics

quarterly cash & cash equivalents:

$4.13B+$125.00M(+3.12%)
March 29, 2025

Summary

  • As of today (May 29, 2025), TMO quarterly cash & cash equivalents is $4.13 billion, with the most recent change of +$125.00 million (+3.12%) on March 29, 2025.
  • Over the past year, TMO quarterly cash & cash equivalents has dropped by -$1.36 billion (-24.82%).
  • TMO quarterly cash & cash equivalents is now -65.63% below its all-time high of $12.03 billion, reached on September 1, 2021.

Performance

TMO quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMObalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

TMO Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.4%-24.8%
3 y3 years-10.4%+50.2%
5 y5 years+67.1%+38.7%

TMO Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.0%at low-51.5%+119.0%
5 y5-year-61.2%+67.1%-65.6%+119.0%
alltimeall time-61.2%>+9999.0%-65.6%>+9999.0%

TMO Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$4.13B(+3.1%)
Dec 2024
$4.01B(-50.4%)
$4.01B(-13.7%)
Sep 2024
-
$4.64B(-34.3%)
Jun 2024
-
$7.07B(+28.6%)
Mar 2024
-
$5.50B(-31.9%)
Dec 2023
$8.08B(-5.2%)
$8.08B(+31.3%)
Sep 2023
-
$6.15B(+96.3%)
Jun 2023
-
$3.13B(-10.0%)
Mar 2023
-
$3.48B(-59.2%)
Dec 2022
$8.52B(+90.4%)
$8.52B(+192.0%)
Sep 2022
-
$2.92B(+54.6%)
Jun 2022
-
$1.89B(-31.4%)
Mar 2022
-
$2.75B(-38.5%)
Dec 2021
$4.48B(-56.6%)
$4.48B(-62.8%)
Sep 2021
-
$12.03B(+71.3%)
Jun 2021
-
$7.02B(+25.8%)
Mar 2021
-
$5.58B(-45.9%)
Dec 2020
$10.32B(+330.4%)
$10.32B(+36.9%)
Sep 2020
-
$7.54B(+29.6%)
Jun 2020
-
$5.82B(+95.2%)
Mar 2020
-
$2.98B(+24.3%)
Dec 2019
$2.40B(+14.1%)
$2.40B(+88.5%)
Sep 2019
-
$1.27B(-44.4%)
Jun 2019
-
$2.29B(+106.9%)
Mar 2019
-
$1.11B(-47.4%)
Dec 2018
$2.10B(+57.5%)
$2.10B(+91.5%)
Sep 2018
-
$1.10B(+17.2%)
Jun 2018
-
$937.00M(-1.4%)
Mar 2018
-
$950.00M(-28.8%)
Dec 2017
$1.33B(+69.8%)
$1.33B(+80.1%)
Sep 2017
-
$741.10M(+21.3%)
Jun 2017
-
$611.00M(-14.3%)
Mar 2017
-
$713.30M(-9.2%)
Dec 2016
$786.00M(+73.9%)
$786.00M(-60.1%)
Sep 2016
-
$1.97B(+197.1%)
Jun 2016
-
$663.10M(-19.8%)
Mar 2016
-
$826.80M(+82.9%)
Dec 2015
$452.10M(-66.3%)
$452.10M(-10.2%)
Sep 2015
-
$503.40M(-34.5%)
Jun 2015
-
$768.40M(-11.1%)
Mar 2015
-
$864.60M(-35.6%)
Dec 2014
$1.34B(-76.9%)
$1.34B(+151.5%)
Sep 2014
-
$534.30M(-8.7%)
Jun 2014
-
$584.90M(-60.9%)
Mar 2014
-
$1.50B(-74.3%)
Dec 2013
$5.83B(+623.2%)
$5.83B(+215.7%)
Sep 2013
-
$1.85B(+31.0%)
Jun 2013
-
$1.41B(+40.3%)
Mar 2013
-
$1.00B(+24.6%)
Dec 2012
$805.60M(-20.7%)
$805.60M(-3.2%)
Sep 2012
-
$832.20M(+13.6%)
Jun 2012
-
$732.30M(-7.1%)
Mar 2012
-
$788.30M(-22.4%)
Dec 2011
$1.02B(+10.8%)
$1.02B(+14.2%)
Sep 2011
-
$890.30M(-34.3%)
Jun 2011
-
$1.36B(-51.4%)
Mar 2011
-
$2.79B(+204.1%)
Dec 2010
$917.10M(-41.4%)
$917.10M(-29.9%)
Jun 2010
-
$1.31B(-8.7%)
Mar 2010
-
$1.43B(-8.5%)
Dec 2009
$1.56B(+22.1%)
$1.56B(-10.4%)
Sep 2009
-
$1.75B(+23.2%)
Jun 2009
-
$1.42B(-9.2%)
Mar 2009
-
$1.56B(+21.9%)
Dec 2008
$1.28B(+104.8%)
$1.28B(+3.2%)
Sep 2008
-
$1.24B(+23.2%)
Jun 2008
-
$1.01B(+37.2%)
Mar 2008
-
$734.00M(+17.4%)
Dec 2007
$625.10M(-6.3%)
$625.10M(-24.8%)
Sep 2007
-
$830.80M(-12.7%)
Jun 2007
-
$951.20M(+41.8%)
Mar 2007
-
$670.90M(+0.5%)
Dec 2006
$667.40M
$667.40M(+322.5%)
DateAnnualQuarterly
Sep 2006
-
$157.96M(-16.7%)
Jun 2006
-
$189.72M(-17.8%)
Mar 2006
-
$230.79M(+7.7%)
Dec 2005
$214.33M(-34.4%)
$214.33M(+10.8%)
Sep 2005
-
$193.46M(+21.1%)
Jun 2005
-
$159.74M(-54.6%)
Mar 2005
-
$351.56M(+7.5%)
Dec 2004
$326.89M(+67.0%)
$326.89M(-2.6%)
Sep 2004
-
$335.66M(+9.5%)
Jun 2004
-
$306.62M(-13.1%)
Mar 2004
-
$352.99M(+80.3%)
Dec 2003
$195.77M(-42.3%)
$195.77M(-5.7%)
Sep 2003
-
$207.55M(-21.5%)
Jun 2003
-
$264.44M(+6.2%)
Mar 2003
-
$249.11M(-26.5%)
Dec 2002
$339.04M(+13.9%)
$339.04M(+45.1%)
Sep 2002
-
$233.60M(-0.6%)
Jun 2002
-
$234.91M(-25.4%)
Mar 2002
-
$315.00M(+5.9%)
Dec 2001
$297.56M(-41.1%)
$297.56M(-12.5%)
Sep 2001
-
$340.19M(-32.8%)
Jun 2001
-
$506.35M(+56.1%)
Mar 2001
-
$324.40M(-35.8%)
Dec 2000
$505.52M(+79.4%)
$505.52M(+57.5%)
Sep 2000
-
$320.96M(+14.1%)
Jun 2000
-
$281.17M(-47.3%)
Mar 2000
-
$533.47M(+89.3%)
Dec 1999
$281.80M(+5.0%)
$281.80M(-33.6%)
Sep 1999
-
$424.30M(+9.7%)
Jun 1999
-
$386.90M(-4.3%)
Mar 1999
-
$404.20M(+50.7%)
Dec 1998
$268.30M(-54.8%)
$268.30M(-35.5%)
Sep 1998
-
$416.10M(-31.9%)
Jun 1998
-
$611.00M(+2.6%)
Mar 1998
-
$595.70M(+0.4%)
Dec 1997
$593.60M(+43.2%)
$593.60M(+20.3%)
Sep 1997
-
$493.30M(+70.9%)
Jun 1997
-
$288.70M(-15.5%)
Mar 1997
-
$341.80M(-17.5%)
Dec 1996
$414.40M(-10.3%)
$414.40M(-18.2%)
Sep 1996
-
$506.50M(-6.4%)
Jun 1996
-
$541.20M(-30.1%)
Mar 1996
-
$774.70M(+67.7%)
Dec 1995
$462.00M(+20.7%)
$462.00M(+4.6%)
Sep 1995
-
$441.60M(-16.5%)
Jun 1995
-
$528.90M(+30.2%)
Mar 1995
-
$406.30M(+6.1%)
Dec 1994
$382.80M(+17.5%)
$382.80M(+24.6%)
Sep 1994
-
$307.20M(+6.0%)
Jun 1994
-
$289.70M(+12.5%)
Mar 1994
-
$257.60M(-20.9%)
Dec 1993
$325.70M(+70.9%)
$325.70M(-5.8%)
Sep 1993
-
$345.60M(+325.1%)
Jun 1993
-
$81.30M(-24.3%)
Mar 1993
-
$107.40M(-43.7%)
Dec 1992
$190.60M(+45.5%)
$190.60M(+14.7%)
Sep 1992
-
$166.20M(+22.7%)
Jun 1992
-
$135.50M(-7.5%)
Mar 1992
-
$146.50M(+11.8%)
Dec 1991
$131.00M(+11.1%)
$131.00M(+18.1%)
Sep 1991
-
$110.90M(+1.2%)
Jun 1991
-
$109.60M(-19.0%)
Mar 1991
-
$135.30M(+14.8%)
Dec 1990
$117.90M(+25.6%)
$117.90M(+40.0%)
Sep 1990
-
$84.20M(+68.7%)
Jun 1990
-
$49.90M(-27.9%)
Mar 1990
-
$69.20M(-26.3%)
Dec 1989
$93.90M(-31.2%)
$93.90M(+45.4%)
Sep 1989
-
$64.60M(-52.6%)
Dec 1988
$136.40M(-5.3%)
$136.40M(-5.3%)
Dec 1987
$144.10M(+125.9%)
$144.10M(+125.9%)
Dec 1986
$63.80M(+112.7%)
$63.80M(+112.7%)
Dec 1985
$30.00M(+163.2%)
$30.00M(+163.2%)
Dec 1984
$11.40M
$11.40M

FAQ

  • What is Thermo Fisher Scientific annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific annual cash & cash equivalents year-on-year change?
  • What is Thermo Fisher Scientific quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific quarterly cash & cash equivalents year-on-year change?

What is Thermo Fisher Scientific annual cash & cash equivalents?

The current annual cash & cash equivalents of TMO is $4.01B

What is the all time high annual cash & cash equivalents for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high annual cash & cash equivalents is $10.32B

What is Thermo Fisher Scientific annual cash & cash equivalents year-on-year change?

Over the past year, TMO annual cash & cash equivalents has changed by -$4.07B (-50.37%)

What is Thermo Fisher Scientific quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of TMO is $4.13B

What is the all time high quarterly cash & cash equivalents for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high quarterly cash & cash equivalents is $12.03B

What is Thermo Fisher Scientific quarterly cash & cash equivalents year-on-year change?

Over the past year, TMO quarterly cash & cash equivalents has changed by -$1.36B (-24.82%)
On this page